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INTRODUCTION 
Serological tests for mumps. 
In a disease like mumps, in which a large percentage of the 
infections are inapparent (1), epidemiological studies are most 
reliable when they classify cases according to the presence or 
absence of a stable, specific antibody, rather than according to 
history. 
Tests availableo The discovery by Levens and Enders in 19U5 
(2) that convalescent sera inhibited hemagglutination by the mumps 
virus led to the hemagglutination inhibition (HI) test, which sub¬ 
sequently proved to be the most accurate index of mumps immunity 
presently available. For years, the HI test has been considered to 
be more sensitive than the complement fixation (CF) test in de¬ 
tecting recent infections (3$h)$ to remain positive longer (5), 
and to be as reliable as the neutralization (N) or skin hyper¬ 
sensitivity tests in detecting previous infections (6). Follow¬ 
ing the Salk modifications in HI technique, nonspecific inhibitors 
in normal sera have not been a problem (3,U)• 
Signifigance of tests. Retrospective studies of mumps immunity, 
to gain an idea of the place of mumps in the broad spectrum of dis¬ 
ease, have seldom been performed. Two reasons for this are the fre¬ 
quency of inapparent mumps infections (rendering histories unreliable) 
and uncertainty about the validity of serological techniques in de¬ 
tecting previous infections. It is uncertain hox«r long mumps anti¬ 
bodies last. It is thought that CF antibodies last about 6 months, 
neutralizing antibodies six years or longer (6), and HI antibodies 
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an unknown period, probably at least as long as neutralizing anti¬ 
bodies* In contrast to the varying persistence of these anti¬ 
bodies, immunity to reinfection with mumps is thought to be life¬ 
long, The accuracy of all these serological tests depends greatly 
on the skill with which they are performed, Maris reported much 
longer persistence of complement-fixing antibodies (28), 
Cross reactions with other viruses. 
Recently, the reliability of the HI test in the diagnosis of 
mumps has been further questioned because studies have indicated 
that other myxoviruses, especially the parainfluenza viruses, can 
stimulate mumps antibodies. 
Nature of viruses related to mumps* All myxoviruses share 
certain physical properties (7,8), The mumps virus is believed to 
contain an antigen system which gives rise to a number of probably 
distinct antibodies (complement fixing, hemagglutinating, and 
neutralizing antibodies) (9), A similar situation may obtain for 
the other myxoviruses. The antigens in different myxoviruses may 
be enough alike to produce antibodies so similar that they cross 
react. 
Extent of cross reactions. This is pertinent to the serology 
of mumps. If infections with another myxovirus, e,g0 parainfluenza, 
gave rise to mumps antibodies (and this is reported to occur) this 
would produce false positive mumps diagnoses. This might create an 
erroneously high percentage of positive tests in non-irnmune persons. 
From serology and history alone these could not be distinguished from 
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inapparent mumps infections. 
The literature abounds with conflicting information about the 
directions of cross reactions (some shown in Figure 6). For example, 
following Chanock (7), Lennette (11) has shown that mumps produces 
a rise in parainfluenza titers. Cross reactions between influenza 
viruses or adenoviruses and mumps were not detected. In his study, 
isolation of viruses was not attempted. Diagnoses were made by 
the clinical picture or serology. The argument that mumps produces 
parainfluenza antibodies because both mumps and parainfluenza anti¬ 
bodies are present is a circular one. The question is whether 
the parainfluenza antibody is similar enough to the mumps antibody 
to render the mumps diagnosis incorrect. 
The recent work of Hsiung (10), however, in which 7 of 10 
cases from which parainfluenza or BA. virus was isolated showed 
signficant rises in mumps antibodies, is strong evidence that para¬ 
influenza does produce mumps antibodies, at least temporarily. 
The situation is made more complex by the recent suggestion 
that parainfluenza viruses may play a role in so-called "second 
cases of mumps" (12). Parainfluenza 1 was isolated, and the titers 
of neutralizing antibodies to that agent rose, in a patient with 
clinical mumps who showed no rise in mumps HI titer. (This sug¬ 
gestion will be discussed later.) 
Epidemiology of mumps. 
Pattern in developed areas. Several important characteristics 
of the epidemiology of mumps might be mentioned. Mumps is an acute 
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infectious disease with distinctive features in typical cases* Its 
mode of transmission is respiratory* In developed areas, between 
60 and 90% of the population have had experience with mumps, by 
history and/or serology (1,28), In about 30% of the cases, infec¬ 
tion was inapparent; though antibodies to mumps are present, the 
subject gives a negative history (1,6). The communicability of 
mumps is less than that of, for example, measles. Evidence for 
this is the considerable percentage of susceptibles of all ages in 
many urban areas, and the existence of whole populations which are 
susceptible. 
Pattern in isolated areas* R. Philip has recently described 
an outbreak of mumps on the isolated island of St. Lawrence (13)* 
Eight-eight percent of the population contracted mumps, as diagnosed 
by clinical picture, and often by a significant rise of CF antibodies. 
As Philip suggested, study of an isolated population allows an inves¬ 
tigator to abstract the “inherent infeetiousness" of an agent, and 
“the inherent susceptibility" of a population. If only one of 
two related agents occurs in an isolated area, the effect of that 
particular agent can be studies without any chance of interference 
by the other agent. 
Theories of partial immunity to mumps in adults. The “Suscep¬ 
tibility" of a population varies most obviously with its past ex¬ 
perience with an infectious agent. But even within a population 
which is highly susceptible and has no easily recognized (historical 
or humoral) past experience of an agent, there may be differences 
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in "inherent susceptibility". For example, Philip (13) found that 
in the St. Lawrence Island mumps epidemic, adults over 35 had the 
lowest attack rate, the lowest morbidity, the highest percentage 
of inapparent infections, and the highest antibody rises following 
clinical infections. This occurred despite the fact that prior to 
the epidemic adults showed no significant mumps titers (but only 
CF antibodies were measured) and there was no history of a mumps 
epidemic for at least 50 years. 
Possible explanations for this are: a decline in "inherent 
susceptibility" with age, i.e., an unknown physiological mechanism. 
Or secondly, the adults could have had experience with mumps in 
the remote past. Philip considers this unlikely. Previous mumps 
experience would probably have produced solid immunity, but the 
reaction of those over 35 years old was a mixture of partial im¬ 
munity and sensitivity. Or thirdly, the adults could have obtained 
some degree of immunity by forming cross-reacting antibodies—• 
experience with "Agent X" giving them some immunity but no persis¬ 
tent, detectable antibodies against mumps. Then the present epi¬ 
demic could have boosted their mumps titers to higher levels than 
were seen in the younger age group. This fits with the fact that, 
in other populations, the incidence of heterologous cross reactions 
is higher in older people than in younger (Lennette’s report on 
mumps (11)). It would be logical to suspect that "Agent X" was a 
member of the myxovirus family. 
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Epidemiology of the parainfluenza viruses. 
Parainfluenza infections are associated with pneumonitis, 
laryngotracheitis, and croup, entities far less distinctive than 
parotitis. These infections occur most often in infants and pre¬ 
school children (21,22) though some have definitely been diagnosed 
in adults. Parainfluenza infections are transmitted by the respira¬ 
tory route. Some of the parainfluenza viruses are highly communi¬ 
cable. Evidence for this are the abrupt outbreaks reported among 
young children and the wide distribution of parainfluenza anti¬ 
bodies in adults, Lennette (11) found that Q0% of his small groups 
of recruits had HI titers of greater than 1:32 against parainfluenza 
1 and 3. Chanock (23) found that only 11% of young (<.5 years) 
children had titers of N antibodies sufficient to provide immunity 
(>li). In the same young group 6l% had titers of neutralizing (N) 
antibodies against parainfluenza 3 of greater than 1:32. Hsiung (10) 
found that in New Haven by 6-10 years of age 90% had significant HI 
titers (20 or 9”) to parainfluenza 3, and 5>0$ to parainfluenza 1. 
La Placa (2li) in a study covering samples from Colorado, Italy, and 
India, found an almost identical pattern in each country. With 
differences of only a few percentage points, about 1*0$ of the chil¬ 
dren (<X0 years) had positive serologies (mostly HI) against para¬ 
influenza 2, and 69% against parainfluenza 3« By adulthood, Qh% 
were parainfluenza 1 positive, J6% Sendai positive, 29% para¬ 
influenza 2 positive, and 97-100$ parainfluenza 3 positive. None 
of his communities were geographically isolated. The sum£ of this 
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experience seems to be that following intermediate titers in child¬ 
hood, adults from many parts of the world have high parainfluenza 
1 and 3 antibodies j fewer have Sendai and parainfluenza 2 antibodies. 
In all of these studies HI and neutralization tests are con - 
sidered to be of nearly equal value (23,2U). The obscurity of the 
disease, the absence of histories, the necessity of isolates, and 
the possibility of second or double infections have combined to 
obviate discussions of the reliability of the serological tests in 
diagnosing individual old infections* 
PURPOSE OF PRESENT STUDY 
In the present paper brief surveys of mumps are made in several 
isolated populations. Observations are made on the histories, and 
mumps antibodies as measured by the HI technique. The reliability 
of mumps HI titers is examined with special reference to duration 
of antibody in the serum and the possible production of mumps false 
positive tests by parainfluenza cross reactions. 
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MATERIALS AND METHODS 
The sera. 
The collection of specimens. After venepuncture, the blood 
was allowed to clot in non-heparinized tubes. The tubes were 
centrifuged to separate clot from serum. Sera were stored at 
~2Q°C from the time of arrival at the field laboratory until 
testing. 
The sources of sera. Sera were available from Baffinland, 
Alaska, Tahiti, and Iceland. 
Many of the Baffinland and Alaskan sera were drawn from 
Eskimos on the mainland of Canada or on the Arctic islands (in 
19h9 and the early 1950's). These people lived as nomads, gathered 
in small villages (under 200), or rarely formed villages as large as 
Point Barrow (population 750). Outside contacts were limited to a 
few freighters and rare airplane visits. Thus, they were semi- 
isolated in the villages, or strictly isolated. Villages were 
periodically swept by severe epidemics of diseases such as pertussis, 
measles, or influenza. Common diseases such as mumps were sometimes 
absent from a population for decades. The Alaskan sera were collected 
by Dr. J.R.Paul, and the Baffinland sera were collected by Dr. 
L. Greenberg (15,16). 
The Tahitian sera were collected by Dr. D.M. Horstraan from 
Polynesian and Chinese natives on the islands of Tahiti and Raiatea 
(1L). Although Tahiti had a population of 30,500, and some areas 
were crowded, there was relatively little contact of natives with the 
outside world. Freighters brought few tourists to the islands. 
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9 
In 1950, the first measles epidemic in 22 years occurred. Paired 
sera, with an 8-year interval, were available from about 90 resi¬ 
dents* of Tahiti. 
The Iceland sera were collected in 1962 by Dr. F.L. Black, 
partly from crowded areas near Reykjavik, but mostly from isolated 
rural areas. Rural areas were isolated enough so that sera could 
be selected for measles susceptibility as a part of another study 
(30,31). 
The ages of supjects. The ages of the persons from whom sera 
were drawn in the isolated areas is shown in Table 1. 
The test for mumps. 
The hemagglutination inhibition (HI) test for mumps was carried 
out using the technique of Robbins (li) who employed the modifications 
of Salk (18) to eliminate nonspecific inhibitors in normal serum, 
with the exception that Sykes monkey red blood cells were used 
instead of chicken red blood cells. 
The treatment of sera. To 0.1 cc of serum, 0.9 cc of a kaolin 
suspension was added (10 parts 2$% kaolin in PBS plus 8 parts of P3S). 
This suspension was allowed to stand 20 minutes, and was then centri¬ 
fuged at 1000 rpm for 10 minutes. The precipitate was discarded. 
To the supernatant .029 cc of packed Sykes RBC's was added, and the 
solution was held for 1 hour at ii°C. Following 10 minutes of cen¬ 
trifugation at 1000 rpm, the RBC button was discarded, and the ex¬ 
tracted serum was stored in the refrigerator. 
ihe antigen. Mumps viral antigen prepared by Microbiological 
Associates and diluted 1:16 was sonicated for 9 minutes to disperse 
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aggregates and increase agglutinating activity. Two tenths cc 
of antigen was diluted serially in 0.2 cc PBS, another 0.2 cc 
of PBS was added to each tube in the row (in place of serum), and 
0.2 cc of i# a 1% solution or Sykes red blood ceils was added 
to each tube. The cells were allowed to settle at room temperature 
and agglutination was read according to the description of Salk. 
A hemagglutinating unit was defined as the maximum dilution of 
virus producing complete agglutination. 
The titration. In the titration of serum, 0.2 cc of serum 
was diluted serially in 0.2 cc of PBS (usually out to 1;32Q). The 
mumps antigen was diluted so that 1 cc contained h hemagglutinating 
units (dilution seldom varied more than twofold, because fresh 
antigen was used), and 0.2 cc of this strength antigen was added 
to each dilution of serum. The mixture of virus and serum was 
allowed to incubate for 1 hour at room temperature. Two tenths cc 
of a 1% suspension of Sykes RBC's was added to each tube, and HI 
was read (Salk) on first settling. The reciprocal of the highest 
dilution showing HI was called the HI titer. 
The test for parainfluenza 1 and 3» 
Parainfluenza titers were measured by the HI technique of 
Hsiung (10,19). 
The treatment of sera. Sera were cleared of nonspecific 
inhibitors either by 0.9 M potassium periodate or by 2%% kaolin 
treatment. 
The antigen. Parainfluenza 1 and 3 virus were grown from 
specimens donated by Dr. G.D. Hsiung in monkey kidney culture with 
HLS (Hanks-lactalbumin-serum) medium. Anti-SV-9 serum was added 
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to prevent interference by that agent. The suparnatant was titrated 
for hemagglutinating activity each day it was used, and the para¬ 
influenza 3 virus was typed with a specific antiserum. No anti¬ 
serum was available to type the parainfluenza 1 virus. 
The titration,, HI tests were performed in polyethylene panels 
or 10 mm tubes. Four units of viral hemagglutinin were added to 
each serum dilution, and a 0.5$ suspension of guinea pig erythro¬ 
cytes was used as the indicator system. 
RESULTS 
Mumps antibody surveys. 
Isolated areas. The sera titrated from Baffinland, Alaska, 
and Tahiti appear to be relatively lacking in mumps antibodies. 
A total of 1*06 sera were tested. A total of 19 or 5% had mumps 
antibody titers of 1*0 or greater (61* or 15$ had titers of 20 or 
greater). 
The distribution of titers varied little among these 3 popula¬ 
tions as shown in Figure 1. There were no titers of 1*0 or more out 
of 25 sera from Baffinland. There were 1* titers of 1*0 or more 
among 98 sera from Alaska (k%)» There were 15 titers of 1*0 or 
more among 283 sera from Tahiti {$%)<> 
Because there were so few high titers, their distribution 
according to age is not presented; high titers were scattered 
through all the age groups show* in Table 1. 
The overall incidence of HI antibodies of h% among Baffin- 
land, Tahitian, and Alaskan sera suggests it is an antibody that 
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is maintained only by repeated exposures which are relatively few 
in these areas. 
Changes in 8-year interval. The Tahitian sera were collected 
at two different times* first in 1951* and later in 1959® Of the 
180 1951 sera, only 6 (or 3%) had titers of i*0 or more. Of the 
103 1959 sera 9 (or 8$) had titers of UO or more. Possible ex¬ 
planations for the difference in these titers are: loss of 1951 
antibody during cold storage (though other antibodies were not lost), 
a higher incidence of mumps after 1951 than before, or a higher 
incidence of cross reactions in 1959. 
Forty-five of the inhabitants of Tahiti were represented by 
sera drawn both in 1951 and 1959. In this group one of the 1*5 sera 
drawn in 1951 had a titer of 1*0 or more (2%); and 6 of the U5 sera 
drawn in 1959 (13%) had titers of 1*0 or more. The one high titer- 
in 1951 declined by 1959 from a titer of 1*0 to one of 10. The 6 
high titers of 1959 had climbed from titers of 10-20 in 1951 to 
titers of l*Q»l6Q in 1959. The 6 persons with titer rises were 11, 
19, 20, 33 and 35 years old in 1959. This is like the age range 
of the population sampled, as shown in Table 1. 
Correlations with parainfluenza serology are reported later 
in the paper. 
Iceland. The survey of mumps antibodies in Iceland shows the 
different patterns of endemic infection (with repeated epidemics). 
Two hundred and sixty-two sera from 11 geographical areas were 
examined. Overall, the average titer of mumps HI antibodies was 35. 
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The average did not vary appreciably from district to district. 
Of the 262 sera* 13b or 51$ had titers of bO or more (22*6 
or %&%, titers of 20 or more)® 
The distribution of titers is shown in Figure 1, Unlike 
Tahiti, Baffinland, and Alaska, in Iceland there were many high and 
few low titers. 
Correlation with age. The distribution of titers according to 
age is shown in Figure 2, where the percentage of the population 
with high, medium or low titers is plotted against age. The num¬ 
bers in each 10-year group are in parentheses at the top of the 
column. Too few sera from children under 10 years old were availa¬ 
ble to give an accurate idea of mumps antibodies in that group. At 
age 10, 29% of the population have high tiers (>b0)j b3$ have medium 
titers ( 20 or bO); and 28% have low titers (<20), This pattern 
persists with little change until age bO. At bO several trends 
begin which culminate at 60; high and low titers decrease, and 
moderate titers climb. At age 60, 8$ of the population have high 
titers, 87$ have moderate titers, and 5$ have low titers. The 
group over 60 years old, like that under 10, contains too few 
specimens to be significant. It must be realized that Figure 2 
represents a cross-section of the population at one point in time, 
not the picture of mumps antibodies changing through time. 
Data published in the Journal of Public Health in Iceland (20) 
show that epidemics have occurred with increasing frequency since 
World War II, Hence the age pattern is not a reflection of contin¬ 
ued exposure to the same influences, but may reflect primarily 
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recent history. 
Correlation with history. Two hundred and thirty-four of the 
Iceland inhabitants gave a mumps history. One hundred and five 
said they had had mumps; 129 said they had not; 6 were doubtful; 
and 25 gave no reply. 
Of the 13U sera with titers of UO or greater, UO gave negative 
histories (see Figure 3). Thus, 30$ acquired mumps antibodies 
without remembered disease. This 30$ is fairly close to the usual 
figure for inapparent mumps infections (1,6). 
There was another group composed of 20 people with positive 
¥• 
histories and mumps titers of less than (see Figure 3). This 
was 17$ of the positive histories recorded in the present sample. 
Other studies (see below) have reported negative or insignificant 
titers in up to 30$ of persons with positive histories. Possible 
explanations of this group are unreliable histories, or decay of 
mumps antibodies. The first explanation would not have been con¬ 
sidered significant until Bloom suggested (12) that there might be 
several viruses causing mumps. 
Decay of mumps antibody i_n_ylvo. Decay of nuHps antibodies 
was hard to estimate because paired sera were not available (except 
in the Tahitian sera where antibodies increased between 1951 and 1959). 
A rough indication of the rate of decay can be obtained from the data 
presented in Figure U. The mean line drawn on this figure is only 
an approximation. 
Forty-nine of the Icelanders gave information on the interval 
since they were infected with mumps. As the graph shows, most of 
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these people (33) had had mumps within 20 years. The group 
infected between 10 and 20 years previously had an average titer 
nearly as high as the group infected within the last 10 years. 
In the groups with infections more than 20 years previously, the 
number of individuals is admittedly small, but the average titers 
and percentages of titers of U0 or more held up, though very 
high titers do not appear. Only one person had a titer of less 
than 20 after a recent infection, and in this case the infection 
had occurred 6 years previous to testing. This Figure suggests 
that mumps HI antibodies, at least after a case severe enough to 
be remembered, persist in good titer for at least 20 years. 
Parainfluenza 1 and 3 antibody surveys. 
The titers of parainfluenza 1 and parainfluenza 3 antibodies 
were measured among inhabitants of Alaska, Baffinland and Tahiti, 
both the 1951 and 1959 specimens. 
Parainfluenza 1. Of 31 sera tested from Alaska and 1*9 sera from 
Tahiti, all the titers of parainlfuenza 1 antibodies were less than 
20. Most of the parainlfuenza 1 titers in the isolated populations 
were run with dilutions beginning at 1:20. Perhaps a number of 1:10 
titers were missed, which some investigators would consider positive. 
Otherwise parainfluenza 1 may be scarce in these populations. 
Parainfluenza 3a The test for parainfluenza 3 antibodies de» 
tected a high prevalence in all three populations. These results 
are shown in Figure 1. 
Among the Alaskan sera 39 out of iUi tested (88$) had a titer 
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of parainfluenza 3 antibodies of 20 or greater# 
Forty-six out of 59 Tahitian sera (77/6) had parainfluenza 
3 titers of 20 or greater. The 2h 1951 specimens and 35 1959 
specimens indicate that the epidemiology of parainfluenza 3 in 
Tahiti did not change markedly between 1951 and 1959* There were 
7h% with titers of 20 or more in 1951 and Q0% in 1959* 
Seven out of 9 Baffinland sera (77%) had parainfluenza titers 
of 20 or greater. 
Correlation with age. The titers are plotted against age in 
Figure 5® There are too few sera from the 2-8 year old group 
to describe accurately the onset of parainfluenza immunity. It 
might be noted, however, that among the Alaskan sera all the para¬ 
influenza 3 titers of 20 or less occur in people who are less than 
15 years old. Also, in general, after 12 years of age there are 
relatively more parainfluenza 3 titers of h0 or greater (75%) 
than in children under 12 (1*0$). This difference held in both 
Alaskan and Tahitian sera. 
Comparison of mumps and paraimiuenza 3 in isolated populations. 
Figure 1 presents the distribution of antibody titers to 
mumps and parainfluenza 3 beside each other. It is clear that, 
in Alaska, BaffinXand, and Tahiti, there are many low and few 
high mumps titers, while in the same populations there are few 
low and many high parainfluenza 3 titers. 
Analysis of correlation between mumps and parainfluenza titers in 
Iceland. 
Although titers of parainfluenza 1, 2, and 3 were run on 108 
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of the Iceland sera, these data could not be used tocfescribe the 
epidemiology of parainfluenza in Iceland because thesera were 
selected in a non-random fashion* 
The sera were selected to provide a group with positive 
mumps histories, and an equal group with negative mumps histories. 
Then each of these groups was further subdivided into equal thirds 
having mumps titers of 80 or greater,titers of 20 or i*0, and mumps 
titers 20. An attempt was made to fill the resultant six groups 
with similar numbers, similar average ages, and sera from a variety 
of geographical districts. Titers of parainfluenza 1, 2, and 3 were 
run. 
On preliminary examination, regardless of the grouping just 
described, some correlations between mumps and parainfluenza were 
of 
seen. For example, of 21 sera with mumps titers xl*Q or more, 16 had 
high titers of parainfluenza 3 (>1*0 )0 But of 3k sera with high para¬ 
influenza 3 titers, only 12 had high titers of mumps. 
Table 2 presents the geometric mean parainfluenza titers in 
sera grouped according to mumps history and titer. To obtain a 
geometric mean, logs to base 2 of parainfluenza titers were average^, 
i.e., 1 for 10, 2 for 20, 3 for 1*0, k for 80, 5 for 160, 60 for 320. 
In the case of each parainfluenza type, the titer correlated 
with the mumps titer. For example, in sera with a positive mumps 
history, the highest parainfluenza 3 average (3.8) was found in the 
group with the highest mumps titers (80 or greater)j and the lowest 
parainfluenza 3 average (2.0) was found in the group with the lowest 
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mumps titers (<20). This trend was observed for each of the para¬ 
influenza viruses in all of the groups, whether mumps histories were 
positive or negative® 
If corss reactions with parainfluenza were giving false mumps 
positive reactions one might expect these to occur where the 
homologous parainfluenza titers were highest® Since no difference 
was found between groups with different mumps histories it s eems 
unlikely that the mumps titers are attributable to parainfluenza 
experience® 
The group with positive histories of mumps and low titers of 
mumps antibodies might be explained by mistaken diagnoses of 
similar diseases or decay of mumps antibodies® Table 2 shows that 
the parainfluenza titers in this group were lower than average, 
suggesting that parainfluenza viruses were not producing atypical 
"mumps” infections® 
The parainfluenza titers were goughly similar in groups with 
similar mumps titers, whether the histories were positive or negative® 
Whatever influence mumps seemed to have on parainfluenza titers 
did not seem to be affected by the mumps history. 
DISCUSSION 
Definition of a "positive” mumps test. 
The definition of ’’positive” or ’’negative” mumps serology 
depends on whether a titer of 20 is considered evidence of past 
infection or not® Among the isolated populations of Tahiti, Alaska, 
and Baffinland the definition makes little difference; there are 
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5$ "positives1’ if 20 is not included, and only 1$% if it is 0 But 
in Iceland, including titers of 20 raises the percentage of posi¬ 
tives from 51 to 1)8. Most likely many of these titers of 20 are 
evidence of past infection. This s eems especially probable in the 
light of the lowering of titers with age shown in Figure 2. For 
the purposes of this paper, it is sufficient to appreciate the low 
incidence of high mumps titers in the isolated populations, and the 
high incidence in Iceland. 
Persistence of mumps antibodies. 
Evidence for the persistence of mumps HI antibodies is the 
data presented in Figure U and the rather small group of Icelanders 
with positive histories and "negative” serologies (Figure 3)* 
Bashe (18) has said that 30$ of those with mumps histories did not 
have neutralizing antibodies. The similar group in this study re¬ 
presents 20 out of llli with positive histories, or 17$. Figure 
h comprises a small number of cases, and the severity of these cases 
cannot be estimated, but it suggests a persistence of elevated titers 
for 20 years or more. The percentage of inapparent infections may 
present confirmatory evidence. If the percentage of inapparent In¬ 
fections were low, one might suppose that the lower titers produced 
by milder infections had died out. But the high average $ of in¬ 
apparent infections in Iceland suggests that HI antibodies persist 
reliably. HI antibodies as measured in this study seem to persist 
longer than neutralizing antibodies found by Bashe et.al. (6), 
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Cross reactions. 
The literature. The cross reactions among the myxoviruses are 
a complicated subject. In Figure 6 the crosses reported in the 
literature are summarized (7,11*10,22,23*19,26,27,29). Arrows point 
from the immunizing agent to the agent against which cross reacting 
antibodies are formed. 
Almost all of these reported cases were followed closely at 
the time of infection in the laboratory. In a number of cases 
(7,10,19,22,23) the immunizing agent was isolated. Double infec- 
tions were not detected nor considered likely because of the fre¬ 
quency and range of cross reactions (10). In other cases (11), 
agents were not isolated, but primary immunizing agents were diag¬ 
nosed by clinical pictures and serology. The serology in most re¬ 
ports consisted of complement fixation or HI tests. The HI tests 
were said to be most sensitive. 
Parainfluenza producing false positive mumps serology. This 
paper addressed itself mainly to the cross reactions between the para¬ 
influenza viruses and mumps; and in particular to false positive mumps 
serology due to prior parainfluenza infections. These false positive 
titers may have been looked on as "inapparent infections'* or "inherent 
insusceptibility" in the old in earlier studies in which the para¬ 
influenza-mumps relationship was not recognized. The evidence pre¬ 
sented against the persistence of these cross reacting antibodies 
is of an epidemiological kins. First, Tahiti, Baffinland, and Alaska 
had considerable experience with parainfluenza 3, but few mumps 
antibodies. Second, in Iceland it was seen that positive para- 
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influenza 1, 2, and 3 serology followed positive mumps serology, and 
not the opposite. That is, individuals who had mumps antibodies 
were more likely to have high parainfluenza titers; but many who 
had parainfluenza antibodies did not have high mumps titers. 
Further there is the data presented in Table 2. If parainfluenza 
were producing false mumps positive reactions, the titers of para¬ 
influenza antibodies would be higher in the group of negative mumps 
histories than in that of positive histories, especially in the group 
of high mumps antibody titer. But the parainfluenza titers were 
similar in groups of similar mumps titers, regardless of mumps his¬ 
tory. In fact, all of the average parainfluenza titers seemed to 
follow mumps titers, and not the opposite. 
‘'Inapparent infections” could have several meanings. At an inter¬ 
mediate level, 3Q-bO$ in the literature, it may refer only to what 
it sayss subclinical mumps infection and positive serology. The fact 
that the incidnbce of inapparent infections remains at an elevated 
level through the upper age groups suggests that the antibody in 
these cases persists although the possibility that it Is periodically 
boosted by a recent epidemic has not been eliminated. If the number 
of persons with no mumps history but positive serology were unusually 
high in some populations, it might suggest a high incidence of cross 
reactions due to prevalence of parainfluenza. In Iceland the number 
of inapparent infections was near the percentage reported in the 
literature. 
This evidence suggests that parainfluenza viruses do not ofen 
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produce lasting mumps antibodies. That cross reactions frequently 
occur in this direction is incontrovertible. 
It is possible that parainfluenza produces some degree of mumps 
immunity without producing detectable complement fixing or HI anti- 
wkts.k 
bodies,unay have occurred in St. Lawrence. But, it seems most likely 
that measurable ''mumps1" antibodies stimulated by parainfluenza infec¬ 
tion remain in the serum only a short time. Hsiung reported one c as© 
where the cross reacting antibody persisted for 3 months (10)* 
Mumps raising parainfluenza titers. There is some evidence in 
Table 2 that the opposite cross reaction in which mumps produces para¬ 
influenza antibodies is a common occurrence® In every subgroup, each 
of the parainfluenza averages correlated with the mumps titer. For 
example, the parainfluenza 3 average was 3.8 in the group with high 
mumps titers, 2.7 in the medium range, and 2.0 in the group with low 
mumps titers. It must be remembered that each point in the log scale 
represents a twofold differences 3.8, a titer of nearly 80, 2.0, a 
titer of 20. With good symmetry this difference is repeated in all 
groups. The isolated correlation might be explained by a cross re¬ 
action in either direction, or a common factor. But, the rest of the 
epidemiology of mumps in Iceland, and the examination of the group 
of inapparent infections, make parainfluenza-to-mumps crosses less 
likely| and no common factor raising both parainfluenza and mumps 
titers is known. This is epidemiological evidence confirming the 
evidence from small groups reported by Lennetie and Chanock (11;7,22), 
that mumps raises parainfluenza titers. 
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Partial immunity to mumps in adults. The "inherent insuscepti¬ 
bility" of older persons described by Philip (13) remains unexplained. 
In the St, Lawrence Island mumps epidemic adults over 35 had the lowest 
attack rate, the lowest morbidity, the highest % of inapparent infections, 
and the highest antibody rises following clinical infections. This 
occurred despite the fact that prior to the epidemic adults showed no 
significant mumps complement fixing titers and there was no history 
of a mumps epidemic for the previous 5>Q years. The implication is that 
there is some degree of mumps immunity in older persons. In this pa¬ 
per there is no evidence that parainfluenza viruses often raise mumps 
HI antibodies. Possible explanations for the inherent insusceptibility 
of older persons remain: a "mumps" antibody other than a CF or HI anti¬ 
body, an agent other than a parainfluenza virus producing the "mumps" 
antibody, or an unknown mechanism. The reliability of the HI test in 
diagnosis and its correlation with insusceptibility make it seem un¬ 
likely that it would detect none of this process* Any of the agents 
in Figure 6 or others, or a combination of agents, might play a part 
in increasing the immunity of older persons. 
Parainfluenza-caused mumps. 
It would be difficult to prove that a parainfluenza virus did 
not occasionally produce a clinical case of mumps, or a second case 
of mumps (12). If such a parainfluenza infection produced cross 
reacting mumps antibodies, diagnosing it would be much more difficult. 
In this paper, the group of Icelanders with positive mumps histories 
but negative mumps serologies might be explained by decay of mumps 
antibodies or parainfluenza-caused "mumps" infection. The first 
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explanation seems more likely for the following reasons. The per¬ 
centage of positive mumps histories with negative serologies is 
rather low, T3$ in Iceland, This seems within the limits of error 
of the HI technique. And secondly, in the group of Icelanders with 
positive mumps histories but negative serologies the parainfluenza 
titers are lower than in any other group. If parainfluenza were 
producing atypical '‘mumps’*, higher parainfluenza titers might have 
been expected. Again, this evidence is only suggestive that such 
atypical parainfluenza-caused cases of "mumps" do not occur often. 
Objections to the suggestion that parainfluenza might occasionally 
produce "mumps" are that diagnosis must be certain and Koch’s postu¬ 
lates should be satisfied (25); but this is not covered in this paper. 
SUMMARY AND CONCLUSIONS 
1) In Alaska, Baffinland, and Tahiti, mumps antibodies were rare 
even though parainfluenza 3 antibodies were common, 
2) Mumps antibodies were common in Iceland. 
3) Mumps HI antibodies persist for 20 or more years. 
li) The low incidence (lti$) of positive mumps histories with low 
HI antibodies, the different epidemiology of mumps and parainfluenza 3 
in the isolated populations, and the Iceland data in Table 2, make 
it unlikely that parainfluenza viruses often produce false positive 
mumps HI tests in normal populations, 
6) the parainfluenza viruses probably do not often produce clinical 
"mumps". 
7) Some immunizing effect of parainfluenza viruses against mumps, 
as suggested in the St. Lawrence epidemic, cannot be excluded. 
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